Low adherence to lipid- lowering therapy is of major concern when the aim is to prevent cardiovascular disease (CVD) in individuals with type 1 diabetes (T1D).

Sociodemographic factors may be part of the explanation for low adherence behavior.

In this study we show that low adherence was associated with male gender, younger age, marital status, country of birth and being a smoker, while individuals with higher incomes less frequently discontinued therapy for dyslipidemia.

These findings illuminate the importance of addressing adherence to treatment at every clinical visit to ensure full cardiovascular protection in individuals with T1D at risk for CVD.